Fusion Biopsy Market Size, Share & Trends Analysis Report By Biopsy Route (Transrectal, Transperineal), By End Use (Hospitals, Diagnostic Centers, Ambulatory Care Centers), By Region (North America, Asia Pacific), And Segment Forecasts, 2025 - 2030

Fusion Biopsy Market Size, Share & Trends Analysis Report By Biopsy Route (Transrectal, Transperineal), By End Use (Hospitals, Diagnostic Centers, Ambulatory Care Centers), By Region (North America, Asia Pacific), And Segment Forecasts, 2025 - 2030


High Performance Polyamides Market Growth & Trends

The global high performance polyamides market size is anticipated to reach USD 3.03 billion in 2030 and is projected to grow at a CAGR of 5.5% from 2025 to 2030. Increasing concerns among consumers and automobile manufacturing companies regarding vehicle efficiency and favorable government regulations regarding the use of polyamides in automotive, electrical and electronics, and consumer goods end-use industries are expected to drive the market over the forecast period.

The demand for high-performance polyamide is expected to increase majorly in the electrical and electronics end-use industry segment owing to the increase in demand for medical electronic devices, home electronics, smart devices, and electrical components to tackle the COVID-19 pandemic situation. The form factor of electronic devices and electrical equipment is getting smaller, and hence requires a high amount of heat dissipation. Additionally, the demand for smart household applications, which require lightweight and thermally conductive plastic components, has risen sharply in recent years. This trend is expected to propel the market growth over the forecast period.

Asia Pacific market is anticipated to witness substantial growth over the coming years owing to various factors such as the presence of government initiatives, such as Make in India, rising number of automotive and medical and healthcare product manufactures, and rising R&D investments for developing new applications of high-performance polyamide by private as well as public organizations. In addition, various medical and healthcare product manufacturing companies have started looking towards India for establishing a manufacturing facility post COVID-19 pandemic situation.

High Performance Polyamides Market Report Highlights
  • The polyamide 12 (PA 12) segment dominated the market, with a revenue share of 20.1% in 2024, due to its excellent chemical resistance and low moisture absorption, making it ideal for environments.
  • The automotive segment dominated the market with the largest revenue share of 39.5% in 2024, this high share is attributed to lightweight metal replacement components to reduce the overall vehicle weight and increase the efficiency
  • Asia Pacific high performance polyamides market dominated the global market with a revenue share of 43.0% in 2024 and is projected to grow at the fastest CAGR of 6.1% from 2025 to 2030
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Biopsy route
1.1.2. End-use
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for Primary Interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for Primary Interviews in Latin America
1.3.5.5. Data for Primary Interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Biopsy route outlook
2.2.2. End-use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Fusion Biopsy Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market Driver Analysis
3.4.1.1. Increasing prevalence of prostate cancer
3.4.1.2. Technological advancements in fusion imaging modalities
3.4.1.3. Increasing funds and investments by public and private sector
3.4.2. Market Restraint Analysis
3.4.2.1. High cost of fusion biopsy system
3.4.2.2. Liquid biopsy system
3.5. Fusion Biopsy Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic Landscape
3.5.3. Major deals & strategic alliances analysis
3.5.4. Market entry strategies
3.5.5. Covid-19 Impact Analysis
Chapter 4. Fusion Biopsy Market: Biopsy Route Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Transrectal
4.1.2. Transperineal
4.2. Biopsy Route Market Share, 2024 & 2030
4.3. Segment Dashboard
4.4. Global Fusion Biopsy Market by Biopsy Route Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Transrectal
4.5.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
4.5.2. Transperineal
4.5.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
Chapter 5. Fusion Biopsy Market: End-use Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Hospitals
5.1.2. Diagnostic centers
5.1.3. Ambulatory care centers
5.2. End-use, 2024 & 2030
5.3. Segment Dashboard
5.4. Fusion Biopsy Market by End-use Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Hospitals
5.5.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.5.2. Diagnostic centers
5.5.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.5.3. Ambulatory care centers
5.5.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
Chapter 6. Fusion Biopsy Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2024 & 2030
6.2. Regional Market Dashboard
6.3. Regional Market Snapshot
6.4. Regional Market Share and Leading Players, 2024
6.4.1. North America
6.4.2. Europe
6.4.3. Asia Pacific
6.4.4. Latin America
6.4.5. Middle East and Africa
6.5. SWOT Analysis by Factor (Political & Legal, Economic and Technological)
6.5.1. North America
6.5.2. Europe
6.5.3. Asia Pacific
6.5.4. Latin America
6.5.5. Middle East and Africa
6.6. Market Size, & Forecasts and Trend Analysis, 2022 to 2030:
6.7. North America
6.7.1. U.S.
6.7.1.1. Key Country Dynamics
6.7.1.2. Regulatory Landscape/Reimbursement Scenario
6.7.1.3. Competitive Landscape
6.7.1.4. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.7.2. Canada
6.7.2.1. Key Country Dynamics
6.7.2.2. Regulatory Landscape/Reimbursement Scenario
6.7.2.3. Competitive Landscape
6.7.2.4. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.7.3. Mexico
6.7.3.1. Key Country Dynamics
6.7.3.2. Regulatory Landscape/Reimbursement Scenario
6.7.3.3. Competitive Landscape
6.7.3.4. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.8. Europe
6.8.1. UK
6.8.1.1. Key Country Dynamics
6.8.1.2. Regulatory Landscape/Reimbursement Scenario
6.8.1.3. Competitive Landscape
6.8.1.4. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.8.2. Germany
6.8.2.1. Key Country Dynamics
6.8.2.2. Regulatory Landscape/Reimbursement Scenario
6.8.2.3. Competitive Landscape
6.8.2.4. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.8.3. France
6.8.3.1. Key Country Dynamics
6.8.3.2. Regulatory Landscape/Reimbursement Scenario
6.8.3.3. Competitive Landscape
6.8.3.4. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.8.4. Italy
6.8.4.1. Key Country Dynamics
6.8.4.2. Regulatory Landscape/Reimbursement Scenario
6.8.4.3. Competitive Landscape
6.8.4.4. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.8.5. Spain
6.8.5.1. Key Country Dynamics
6.8.5.2. Regulatory Landscape/Reimbursement Scenario
6.8.5.3. Competitive Landscape
6.8.5.4. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.8.6. Denmark
6.8.6.1. Key Country Dynamics
6.8.6.2. Regulatory Landscape/Reimbursement Scenario
6.8.6.3. Competitive Landscape
6.8.6.4. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.8.7. Sweden
6.8.7.1. Key Country Dynamics
6.8.7.2. Regulatory Landscape/Reimbursement Scenario
6.8.7.3. Competitive Landscape
6.8.7.4. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.8.8. Norway
6.8.8.1. Key Country Dynamics
6.8.8.2. Regulatory Landscape/Reimbursement Scenario
6.8.8.3. Competitive Landscape
6.8.8.4. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.9. Asia Pacific
6.9.1. Japan
6.9.1.1. Key Country Dynamics
6.9.1.2. Regulatory Landscape/Reimbursement Scenario
6.9.1.3. Competitive Landscape
6.9.1.4. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.9.2. China
6.9.2.1. Key Country Dynamics
6.9.2.2. Regulatory Landscape/Reimbursement Scenario
6.9.2.3. Competitive Landscape
6.9.2.4. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.9.3. India
6.9.3.1. Key Country Dynamics
6.9.3.2. Regulatory Landscape/Reimbursement Scenario
6.9.3.3. Competitive Landscape
6.9.3.4. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.9.4. South Korea
6.9.4.1. Key Country Dynamics
6.9.4.2. Regulatory Landscape/Reimbursement Scenario
6.9.4.3. Competitive Landscape
6.9.4.4. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.9.5. Thailand
6.9.5.1. Key Country Dynamics
6.9.5.2. Regulatory Landscape/Reimbursement Scenario
6.9.5.3. Competitive Landscape
6.9.5.4. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.9.6. Australia
6.9.6.1. Key Country Dynamics
6.9.6.2. Regulatory Landscape/Reimbursement Scenario
6.9.6.3. Competitive Landscape
6.9.6.4. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.10. Latin America
6.10.1. Brazil
6.10.1.1. Key Country Dynamics
6.10.1.2. Regulatory Landscape/Reimbursement Scenario
6.10.1.3. Competitive Landscape
6.10.1.4. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.10.2. Argentina
6.10.2.1. Key Country Dynamics
6.10.2.2. Regulatory Landscape/Reimbursement Scenario
6.10.2.3. Competitive Landscape
6.10.2.4. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.11. MEA
6.11.1. South Africa
6.11.1.1. Key Country Dynamics
6.11.1.2. Regulatory Landscape/Reimbursement Scenario
6.11.1.3. Competitive Landscape
6.11.1.4. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.11.2. Saudi Arabia
6.11.2.1. Key Country Dynamics
6.11.2.2. Regulatory Landscape/Reimbursement Scenario
6.11.2.3. Competitive Landscape
6.11.2.4. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.11.3. UAE
6.11.3.1. Key Country Dynamics
6.11.3.2. Regulatory Landscape/Reimbursement Scenario
6.11.3.3. Competitive Landscape
6.11.3.4. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.11.4. Kuwait
6.11.4.1. Key Country Dynamics
6.11.4.2. Regulatory Landscape/Reimbursement Scenario
6.11.4.3. Competitive Landscape
6.11.4.4. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competitive Categorization
7.2.1. Innovators
7.2.2. Market leaders
7.2.3. Emerging players
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2024
7.4. Public Companies
7.4.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
7.4.2. Company market share/ranking, by region
7.4.3. Competitive dashboard analysis
7.4.3.1. Market differentiators
7.4.3.2. Synergy analysis: major deals and strategic alliances
7.5. Private Companies
7.5.1. List of key emerging companies/technology disruptors/innovators
7.5.2. Funding outlook
7.5.3. Regional network map
7.5.4. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
7.5.5. Supplier ranking
7.5.6. Key company profiled
7.5.7. Eigen
7.5.7.1. Company overview
7.5.7.2. Financial performance
7.5.7.3. Product benchmarking
7.5.7.4. Strategic initiatives
7.5.8. Koninklijke Philips N.V.
7.5.8.1. Company overview
7.5.8.2. Financial performance
7.5.8.3. Product benchmarking
7.5.8.4. Strategic initiatives
7.5.9. Hitachi, Ltd.
7.5.9.1. Company overview
7.5.9.2. Financial performance
7.5.9.3. Product benchmarking
7.5.9.4. Strategic initiatives
7.5.10. MedCom
7.5.10.1. Company overview
7.5.10.2. Financial performance
7.5.10.3. Product benchmarking
7.5.10.4. Strategic initiatives
7.5.11. ESAOTE SPA
7.5.11.1. Company overview
7.5.11.2. Financial performance
7.5.11.3. Product benchmarking
7.5.11.4. Strategic initiatives
7.5.12. KOELIS
7.5.12.1. Company overview
7.5.12.2. Financial performance
7.5.12.3. Product benchmarking
7.5.12.4. Strategic initiatives
7.5.13. Focal Healthcare
7.5.13.1. Company overview
7.5.13.2. Financial performance
7.5.13.3. Product benchmarking
7.5.13.4. Strategic initiatives
7.5.14. GeoScan Medical
7.5.14.1. Company overview
7.5.14.2. Financial performance
7.5.14.3. Product benchmarking
7.5.14.4. Strategic initiatives
7.5.15. UC-Care Medical Systems Ltd.
7.5.15.1. Company overview
7.5.15.2. Financial performance
7.5.15.3. Product benchmarking
7.5.15.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings